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Supernatants (Sn) 1 from T  cell-containing cultures stimulated with either antigens 
or mitogens have been the source of nonspecific helper factors for many years (1-6). 
Such Sn have the ability to restore the antibody response of T  cell-depleted spleen 
cells to the antigen, sheep erythrocytes (SRBC).  Some of the active principle(s)  in 
these Sn have been shown to have an -30,000-40,000 tool wt by Sephadex chroma- 
tography (2-6). Recently, one factor shown to be present in this fraction is interleukin 
2 (IL-2; formerly, T  cell growth factor) (7-8). Although purified IL-2 has been shown 
to stimulate B cell responses to SRBC, its powerful T  cell growth-promoting activity 
has left open thq possibility that its activity in B cell responses is mediated indirectly 
by its stimulation of the small number of T  cells contaminating most B cell prepara- 
tions and that other factors are the ultimate stimulators of B cell responses. 
We continued our comparison of the helper T  cell-replacing activity of IL-2 to that 
of other  factors present  in  the  Sn  of normal  murine  spleen  cells  stimulated  with 
Concanavalin A  (normal Con ASn)  (9). In the in vitro response of B cells to SRBC, 
both a factor indistinguishable from IL-2 and a second factor(s) with an ~40,000 mol 
wt were found to be essential in replacing helper T  cell activity when using severely 
T  cell-depleted B cells, although IL-2 alone was sufficient in the presence of only a 
few  contaminating  T  cells.  Our  results  suggest  that  IL-2  can  influence  antibody 
responses  through  both  an  obligatory direct  effect on  responding  B  cells  and  an 
indirect effect via the stimulation of T  cells that produce a second required factor(s). 
Materials and Methods 
Mice.  B6D2F1, B6AFx, C57BL/10SgSn  (B10), B10.A, B10.D2,  B10.BR  AKR,  and  C58 
mice were purchased from The Jackson Laboratory, Bar Harbor, Maine, or in some cases were 
bred in our facilities from breeding stock obtained from The Jackson Laboratory. The following 
mice were  bred  in  our facilities  from breeding stock  obtained from the sources  indicated: 
D1.LP,  B10.A(5R),  and  B10.M  (The Jackson  Laboratory); B10.A(4R)  (Dr. J.  Stimpfling, 
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Rocky Mountain National Laboratory, Great  Falls, Mont.); B10.AQR  (Dr.  C.  David, The 
Mayo  Clinic,  Rochester,  Minn.);  B10.S(7R),  A.TH,  A.TL,  and  A.AL  (Dr.  D.  Shreffler, 
Washington University, St. Louis, Mo.).  Outbred nu/nu mice were bred in our own facilities 
from nu/+ stock. 
Antigens and Other Reagents.  SRBC from a single animal (220) were obtained from Colorado 
Serum Company, Denver, Co. Con A was purchased from Miles-Yeda, Rehovoth, Israel, and 
a-methylmannoside (a-MM) was obtained from the Sigma Corporation, St. Louis, Mo. 
Cultures.  Cell suspensions were cultured by modifications (10, 11) of the methods of Mishell 
and Dutton (12). B cell responses to SRBC were obtained in 96-well microcuhure plates (Costar 
Data Packaging, Cambridge, Mass.).  Unless stated otherwise,  cultures contained 1.5 X 105 T- 
cell depleted spleen cells in a volume of 0.1 ml, SRBC at a concentration of 0.05%, and a-MM 
at a concentration of 10 mg/ml. Anti-SRBC plaque-forming cells (PFC) were enumerated on 
day 4 of culture, using an in situ PFC assay (10). Results are reported as the total number of 
anti-SRBC PFC assayed in twelve identical microcuhure wells. 
T Cell Hybridomas.  We originally described the T cell hybrid FS6-14.13, which was derived 
from the fusion of the AKR thymoma, BW5147,  to normal T  cells from B6D2FI mice. This 
hybrid was demonstrated to produce IL-2 when stimulated with Con A (9). In most experiments 
described below this hybrid was used as the source of IL-2. 
In one experiment, the Con A-stimulated Sn of FS6-14.13 was compared to those produced 
with a series of similarly derived hybrids. FS7-8 and FS7-59 were derived from the fusion of 
BW5147 to normal T cells from B10.BR mice. FS8-1, FS8-4, FS8-5, FS8-7, FS8-14, and FS8-16 
were derived from the fusion of BW5147 to normal T cells from AKR mice. These hybrids were 
chosen because when stimulated with Con A they produced a wide range of IL-2 concentrations 
from little or no IL-2 produced (e.g., FS8-5) to very high levels of IL-2 (e.g., FS7-59). 
Con ASn Production.  Con ASn was prepared from the T cell hybrids, as previously described, 
by incubation overnight at 5 X 105 to 5 ×  l0  s cells/ml in medium containing 4/~g/ml Con A. 
The cell-free Sn were stored at -20°C until used. 
To prepare normal Con A Sn B6AFx or B6D2F1, spleen cells were cultured at 107 cells/ml in 
medium containing 4/~g/ml Con A (3). The cell-free supernatant was then filtered through a 
0.2/~m filter and stored at -20°C until used. In some experiments an IL-2-depleted normal 
Con ASn was prepared by culturing spleen cells at  10  v cells/ml for 4 d with 4/~g/ml Con A. 
In this case, cultures were fed on day 1 and day 2 with Mishell/Dutton nutrient cocktail (12). 
The cell-free Sn was filtered and stored as above. 
Concentration of Sn.  A concentrated Con A Sn ofFS6-14.13 was prepared by stimulating the 
hybrid cells for 24 h at 106 cells/ml with 3 #g/ml Con A in medium containing  only 0.5% fetal 
calf serum (FCS)  (instead of the usual 5%). After the method of Watson et al.  (5), a-MM was 
added to this Sn to a concentration of 0.1  M. Ammonium sulfate was then added to 40% of 
saturation, and the small precipitate was removed by centrifugation. Ammonium sulfate was 
then added to 80% of saturation and the collected precipitate redissolved  in a small volume of 
0.15  M  NaCI, dialyzed extensively against 0.15  M  NaC1 followed  by balanced salt solution. 
This preparation was then sterilized by filtration and stored frozen until used. This procedure 
resulted in recovery of virtually all of the IL-2 in the original Sn, with an overall concentration 
of about 50-fold. 
A 4-d normal Con ASn depleted of IL-2 was concentrated similarly. Normal spleen cells 
were  incubated for 4 d  in medium containing 4 #g/ml Con A and 2.5% FCS. This Sn was 
fractionated with  ammonium sulfate,  dialyzed, and  sterilized as  above.  Again the  overall 
concentration was -50-fold. 
Assay for  T  Cell Growth-promoting Activity  of IL-2.  IL-2 preparations were assayed for their 
ability to stimulate T  cell growth using the IL-2-dependent T  cell line HT-2 (kindly given to 
us by Dr. J. Watson, University of California, Irvine, Calif.).  Although originally reported as a 
cloned helper T cell line (13), the subline growing in our laboratory had lost its helper activity 
while retaining its absolute dependence on IL-2 for viability and growth. In the absence of IL- 
2, HT-2 was <5% viable after 24 h, whereas in the continuous presence of IL-2, viability was 
>95%. To assay for IL-2, 4 ×  103 viable HT-2 cells were cultured for 24 h in 0.1 ml of medium 
containing twofold dilutions of the unknown preparation. Cultures were then examined with 
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Those with <10% viable cells were scored  negative. Cultures with  10-90%  viable cells were 
scored  intermediate. For a given sample, the first dilution to be scored  less than positive was 
defined as containing 1 U of IL-2. By this assay the 24-h normal Con A Sn and FS6-14.13 Con 
ASn used in these experiments contained between 250-1,000 U of IL-2/ml. 
Absorption of Con ASn.  Three cell preparations were used to absorb IL-2 from normal Con 
A Sn. The first was a preparation of normal spleen cells incubated at 107 cells/ml for 48 h with 
4/~g/ml Con A (14). The second population was the nylon fiber nonadherent T cell blasts from 
these  Con A-activated spleen cells.  The  third  was  the  IL-2-dependent cell line, HT-2  (see 
•  "  °  "  1  above}. Absorptions were performed by mcubatmgTnormal Con ASn for 20 h at 37  C with 
×  10/ml  Con  A-activated  spleen  cells,  1  ×  10/ml  Con  A-activated splenic T  cells,  or 
5 ×  108/ml HT-2 T cells. The cell-free supernatants were then filtered and stored at -20°C. As 
stated above, as a  fourth method of producing IL-2-depleted normal Con ASn, we cultured 
normal spleen cells at  107/ml  in 4/xg/ml Con A  for  4 d  instead of 1 d.  Such cultures first 
produce and then consume IL-2.  Supernatants were then harvested, filtered, and stored  at 
-20°C. All four methods of IL-2 depletion resulted in preparations that failed to support the 
growth of HT-2 cells even when used undiluted (<10 U of IL-2/ml). 
In addition, similar absorptions were performed with various non-IL-2-dependent cells to 
establish  the  specificity of the  IL-2  absorptions.  These  negative control  absorptions were 
performed with normal spleen cells (107/ml),  anti-T cell serum plus complement-treated 48-h 
LPS-induced B6D2F1 B cell blasts (107/ml),  P3X63AG8.653, a nonimmunoglobulin-secreting 
variant of the BALB/c myeloma, MOPC-21 (5 ×  106/ml), and BW5147 (5 ×  106/ml). None of 
these absorptions removed IL-2 from the Con ASn. 
Antisera and Hybridoma Antibodies.  Anti-thymocyte serum (ATS) was purchased from Micro- 
biological Associates, Walkersville, Md. To prepare a T cell-specific reagent, ATS was absorbed 
as previously described (15) with the myeloma, XS63, obtained from the Cell Distribution 
Center,'The Salk Institute, La Jolla, Calif. or the B cell tumor, CH-1, kindly provided by Dr. 
Noel Warner, University of New Mexico, Albuquerque, N. M. The rat anti-Thy-  1 hybridoma 
T24/40.7 was obtained from Dr. Ian Trowbridge, The Salk Institute, La Jolla, Calif. Ascitic 
fluid from  the  anti-Qat-4 hybridoma, B16/146,  and anti-Qat-5 hybridoma, B16/167,  were 
kindly provided by Dr. Ulrich Hammerling, Sloan Kettering Memorial Cancer Institute, New 
York (16). 
The hybridoma MK-2.2 was  produced in this laboratory from the fusion of the BALB/c 
myeloma, 45.6TG1.7 (MPC-11) to spleen cells from A.TH mice that had been hyperimmunized 
with A.TL Con A-activated T  cell blasts (17). The supernatants of the hybrids were screened 
with rabbit complement (C) for cytotoxic activity on normal A.TL T cells. MK-2 tested positive 
in this assay. The hybrid was cloned to yield MK-2.2, which was used in these studies. 
Although in the original immunization we were attempting to produce anti-la antibodies, 
MK-2.2 turned out to have a  very unusual auto-antibody specificity,  as shown in Table I. 
When used with rabbit complement, MK-2.2 antibody killed >90% of splenic T  cells in all 
strains tested regardless of background or H-2 type, including  A.TH, the strain of origin. When 
tested with spleen cells that had been depleted ofT cells with anti-Thy-1 antibody and C, MK- 
2.2 killed up to 30% of the cells. However, this non-T cell killing was linked to the D end of H- 
2. All strains that carried H-2D  a, including A.TH, showed ~20-30% killing of non-T cells. All 
other strains tested showed no or very little killing of non-T cells  (0-10%).  The B cells that 
survived treatment with MK-2.2 antibody and C in H-2D a strains were unaffected in their in 
vitro response to a variety of antigens (TNP-FicoI1, TNP-lipopolysaccharide, and SRBC) (data 
not shown). MK-2.2, therefore, had an unusual reactivity reminiscent of a Qa specificity (16, 
18,  19) in that it showed a linkage to H-2D and was detectable on T  cells and non-T/non-B 
cells but apparently was absent from most B cells. 
Depletion of T Cells  from Spleen Cells.  Spleen cells were thoroughly depleted of T cell activity 
as follows. 2 d before killing, mice were injected with 0.04 ml of ATS to remove recirculating 
T  cells  (20). Spleen cells  from these  mice were  incubated at  0°C  for 30  min at  3.3  ×  107 
cells/ml with an antibody cocktail containing the following ingredients: 5% T24/40.7 culture 
Sn;  1%  B  cell-absorbed ATS;  0.2%  B16/146  and  B16/167  ascitic  fluid;  and  4%  of ×  50 
concentrated MK-2.2 culture Sn. The cells were then centrifuged, resuspended to the original 1684  B  CELLS  REQUIRE  AT  LEAST  TWO  HELPER  FACTORS 
TABLE  I 
Specificity of MK-2. 2 Antibody 
H-2 regions 
Strain  Tla 
Percent cytotoxicity 
with MK-2.2 antibody 
and rabbit C' 
Non-T  K  A  B  J  E  C  S  G  D  T cells  cells 
A.TH  s  s  s  s  s  s  s  s  d  a  >90%  29 
BI0.S(7R)  s  s  s  s  s  s  s  s  d  a  >90%  31 
A.TL  s  k  k  k  k  k  k  k  d  c  >90%  25 
A.AL  k  k  k  k  k  k  k  k  d  c  >90%  21 
B10.D2  d  d  d  d  d  d  d  d  d  c  >90%  33 
B 10.A  k  k  k  k  k  d  d  d  d  a  >90%  30 
B 10.AQR  q  k  k  k  k  d  d  d  d  a  >90%  37 
B10.A(5R)  b  b  b  k  k  d  d  d  d  a  >90%  39 
B10  b  b  b  b  b  b  b  b  b  b  >90%  9 
D 1.LP  b  b  b  b  b  b  b  b  b  c?/b?  >90%  8 
BI0.A(4R)  k  k  b  b  b  b  b  b  b  b  >90%  10 
B10.M  f  f  f  f  f  f  f  f  f  d  >90%  0 
C58  k  k  k  k  k  k  k  k  k  a  >90%  5 
BI0.BR  k  k  k  k  k  k  k  k  k  a  >90%  2 
T  cells were prepared from spleen cells of strains shown using nylon fiber columns. Splenic non-T cells 
were prepared by pretreatment with anti-Thy-1 and C  followed  by isolation of the surviving cells on a 
Ficoll-Hypaque step gradient. The cytotoxic activitny of MK-2.2 antibody was determined by preincubating 
T  cells  or non-T cells  for  1 h  at 0°C  at 4  ×  10  cells/ml in neat culture supernatant taken from the 
hybridoma cells. The cells were washed several times and resuspended in  1:15 rabbit C. After 45 rain at 
37 °, viabilities were determined using trypan blue. The percent dead cells are shown after correction for 
cytotoxicity seen with C alone. 
volume in  1:15 C  (Microbiological Associates, Walkersville, Md.), and incubated at 37°C  for 
30 min. The cells were then centrifuged, washed once, and resuspended in culture medium. 
Results 
To test the idea that the activity of IL-2 as a  B  cell helper factor was dependent  on 
its stimulation  of the T  cells contaminating  most  B  cells prepared  with conventional 
techniques,  we set out  to find a  more  effective means  of T  cell depletion.  Our  initial 
experiments  (9) confirmed that IL-2 would stimulate an anti-SRBC  response in spleen 
cells  depleted  of T  cells  by  treatment  with  either  monoclonal  anti-Thy-1  or  rabbit 
anti-T  cell  serum  and  C.  Supplementing  this  treatment  by  injecting the  spleen  cell 
donors  with  ATS  2  d  before  killing  and  including  a-MM  in  the  B  cell  cultures 
dramatically  reduced  the  stimulation  seen  with  IL.2,  indicating  that  the  response 
depended  on T  cells contaminating  the B  cell preparation. 
In  more  recent  experiments,  we  found  that  supplementing  the  anti-Thy-1  and 
rabbit  anti-T  cell  antibodies  with  the  anti-Qa  and  Qa-like  monoclonal  antibodies 
B16-146,  B16-165,  and  MK2.2  resulted  in  a  treatment  protocol  that  even  more 
reliably resulted  in a  B  cell preparation  unable  to  respond  to  SRBC  in the presence 
of IL-2  alone.  Our  rationale  in  using  these  additional  antibodies  was  that  because 
they were effective against a  large proportion  of Thy-1-  non-B cells, they might  aide 
in  the killing of both  mature  T  cells that  had  low  levels of Thy-1  and  immature  T 
cells  (pre-T  cells?)  that  might  be  stimulated  to  differentiate  in  culture  to  produce H. JAMES LEIBSON,  PHILIPPA MARRACK,  AND JOHN W.  KAPPLER  1685 
additional helper factors. 
A  comparison  of the  responses  of T  cell-depleted  spleen  cells  prepared  in  this 
manner  and spleen  cells  from nu/nu  mice is  shown  in Table  II. Both preparations 
failed to respond to SRBC without additional helper factors. Both responded well in 
the presence of normal Con ASn.  However, when using FS6-14.13 Con ASn,  only 
the nu/nu  spleen cells responded.  These results confirmed that IL-2 was a  sufficient 
helper factor only in the presence of T  cells and that conventional B cell sources such 
as nu/nu  mice contained substantial  T  cell activity that could be revealed by IL-2. 
The  ability  of IL-2  to  enhance  the  activity  of a  small  number  of T  cells  was 
demonstrated  even  more dramatically  in experiments  in which  various  numbers  of 
untreated  spleen  cells were added  back to cultures  of thoroughly T  cell-depleted  B 
cells in the presence of various helper factor preparations  (Fig.  1). As before, these B 
cells cultured either with control medium containing Con A  or with FS6-14.13 Con 
ASn  failed to respond to SRBC, although a response was obtained with normal Con 
ASn.  However, when as few as  1,000 normal spleen cells (<1%) were added to these 
cultures, a significant response was obtained with FS6-14.13 Con ASn. Similar results 
were obtained using nylon fiber-purified splenic T  cells (data not shown). 
These  results  further  demonstrated  that  for IL-2 to be a  sufficient  helper  factor, 
cultures had to contain some T  cell activity and point  to the presence of additional 
helper factors in normal Con ASn. 
Both  IL-2  and  Another  Factor(s)  in  Normal  Con  ASn  Are  Required  for  B  Cell 
Responses.  Although our experiments established that IL-2 was not a sufficient helper 
factor for highly T  cell-depleted B cells, they did not address the question of whether 
IL-2 was a  necessary helper factor for B cells in the absence of T  cells. The fact that 
normal  Con ASn  stimulated  responses  even  in  thoroughly T  cell-depleted  B  cells 
suggested  that  factors other  than  IL-2 might  be the  ultimate  active principles  and 
that  all  the effects of IL-2 might  be mediated  via T  cells.  If this  were the case, we 
reasoned that the removal of IL-2 from normal Con ASn should have no effect on its 
helper activity. 
To  test  this  prediction,  we removed  IL-2 from normal  Con A  Sn  by incubation 
with  IL-2-dependent T  cells.  We used Con A-activated normal  spleen  cells, T  cells 
isolated  from these  Con A-activated  spleen  cells,  and  the  IL-2-dependent  cell  line, 
HT-2, for this purpose. The results of these experiments are shown in Table III. In all 
TABLE  II 
IL-2 Requires the Presence of T Cells to Be a Sufficient Helper Factor 
Total anti-SRBC PFC  B cell source  Helper factors  in 12 microcultures 
nu/nu spleen cells  None  0 
FS6-14.13 Con ASn  629 
Normal Con ASn  480 
Normal B6D2F1 spleen (ATS in vivo; 
anti-T cell cocktail + C in vitro) 
None  0 
FS6-14.13 Con ASn  17 
Normal Con ASn  625 
Nu/nu spleen cells were cultured at 2.5 x  10  s cells/microculture in medium containing nothing, 40% FS6- 
14.13 Con ASn, or 30% normal Con A Sn. T cell-depleted B6D2F1 spleen cells were cultured at  1.5 x  l0  s 
cells/microculture in medium containing nothing, 40% FS614.13 Con ASn, or 40% normal Con ASn. 1686  B  CELLS  REQUIRE  AT  LEAST  TWO  HELPER  FACTORS 
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Fro.  1.  A small number of T  cells renders IL-2 a  sufficient helper factor. T  cell-depleted spleen 
cells were prepared from B6AF1  mice, as described in  Materials and Methods. Untreated spleen 
cells from normal B6AF~ mice were also prepared. Various mixtures of these two cell preparations 
were cultured  (keeping the total  cell  concentration  at  1.5  ×  105 cells/culture  well)  in  medium 
containing 30% FS6-14.13 Con ASn (Q), 30% normal ConA Sn (i), or 30% medium containing 4 
/.tg/ml Con A (A). All cultures received et-MM to a  final concentration of 10 mg/ml and SRBC as 
antigen. Anti-SRBC PFC were assayed 4 d  later. Results are reported as the total PFC in twelve 
culture wells vs. the fraction of untreated normal spleen cells in the culture.  Similar results were 
obtained in two additional experiments. 
cases, the IL-2-depleted Sn lost its ability to support the response of T  cell-depleted B 
cells.  In each case, FS6-14.13 Con ASn,  although unable to support a  response by 
itself, restored the helper activity of the absorbed Sn. 
To  help  establish  that  these  absorptions  resulted  in  specific absorption  of IL-2 
rather than in nonspecific destruction of various essential factors in the normal Con 
ASn, we performed a  number of control absorptions with  various cell types other 
than IL-2-dependent T  cells. These included normal spleen cells, LPS-activated B cell 
blasts, the T cell tumor line, BW5147, and a nonimmunoglobulin-secreting variant of 
TABLE  III 
B  Cells Require IL-2 and a Second Factor(s) Present in Normal Con ASn 
Helper factor 
Total anti-SRBC PFC in  12 microcuhures 
Experiment  Experiment  Experiment  Experiment 
1  2  3  4 
None  0  0  0  0 
Normal Con ASn*  327  373  223  156 
FS6-14.13 Con A Sn:]:  5  19  25  5 
IL-2-depleted normal Con ASn*§  19  0  0  0 
FS6-14.13  Con  A  Sn:~ +  IL-2-depleted  143  439  309  217 
normal Con ASn*§ 
* Normal Con ASn and II-2-depleted normal Con ASn concentrations: experiment 1, 40%; experiment 2, 
60%; experiment 3, 30%, experiment 4, 20%. 
:~FS6-14.13  Con  ASn  concentrations:  experiment  1,  40%;  experiment  2,  20%;  experiment  3,  40%; 
experiment 4, 40%. 
§IL-2  depletion  of normal  Con  ASn:  experiment  1,  absorption  with  Con  A-activated  spleen  cells; 
experiment 2, absorption with Con A-activated splenic T  cells; experiment 3, absorption with HT-2 T 
cells; experiment 4,  preparation of 4-d normal Con ASn. See Materials and Methods for details. Each 
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MOPC  21.  These absorbed Sn were compared to Sn  absorbed with  either Con  A- 
activated spleen  cells or HT-2  in  their  ability to support  either  HT-2  growth  and 
viability or the  anti-SRBC  response of T  cell-depleted spleen cells.  The results  are 
presented  in Table IV. None of the control absorptions removed IL-2 from normal 
Con  ASn,  as judged  by the  growth  of HT-2.  Similarly, these  absorptions  had  no 
effect on the ability of the Sn to support an anti-SRBC  PFC response. However, as 
before, absorption with either Con A-activated spleen cells or with HT-2 cells removed 
both the T  cell growth activity of the Sn and its ability to support an antigen-SRBC 
PFC response. Also as before, the addition of FS6-14.13 Con A Sn to the IL-2-depleted 
Sn fully restored the anti-SRBC PFC response. 
The  results  of these  experiments  indicated  that  at  least  two  helper  factors were 
required  in  the  B  cell  response.  Both  were present  in  normal Con  ASn.  One  was 
specifically absorbed by IL-2-dependent T cells and the other was not. The absorbable 
factor could be supplied by FS6-14.13  Con ASn but the nonabsorbable factor could 
not. These findings strongly implicated IL-2 as an essential component in FS6-14.13 
Con ASn, but because of the controversy over the possible effects of IL-2 on non-T 
cells, we performed an experiment to try to strengthen this conclusion. 
We tested Con A  Sn derived from a bank of independently derived T  cell hybrids 
chosen to contain a wide range of IL-2 concentrations determined by the support of 
HT-2 growth and viability. Table V  lists the hybrids and the levels of IL-2 present in 
their Con ASn  used in this experiments. They ranged from  1,800  U/ml in the Con 
A Sn of FS7-59 down to no detectable IL-2 in a number of Sn. These Sn were titered 
in cultures containing T  cell-depleted B cells, SRBC, and excess IL-2-depleted normal 
Con ASn, and the anti-SRBC PFC were assayed on day 4. The results are shown in 
Fig. 2.  No response was obtained with IL-2-depleted normal Con ASn.  Restoration 
of the response was related to the level of IL-2. As described in the legend to Fig. 2, 
these data were used to estimate the units of activity of these Sn in the anti-SRBC 
PFC response. These estimates are listed in Table V. A  comparison of U/ml in the 
HT-2 growth assay vs. the anti-SRBC PFC response shows a high degree of correlation 
(r =  0.96).  From this data, one can calculate that under the conditions of these two 
TABLE IV 
Effect of Absorption of Normal Con ASn with  Various Cell Types 
Absorbing cell* 
Activity of normal Con ASn 
Units/ml IL-2  PFC/12 microcultures:[: 
assayed on 
Plus FS6-14.13  HT-2  Alone 
Con A Sn 
None  320  137  163 
Normal spleen cells  230  153  236 
LPS-activated B cells  450  123  236 
Con A-activated spleen cells  < 10  < 12  152 
HT-2  <I0  <12  238 
MOPC-21  320  104  2 l0 
BW5147  230  197  249 
*  See Materials and Methods for details. 
:1: B cells from B6D2Fa mice. Normal Con ASn, 30%.  FS6-14.13 Con ASn, 0.5% of a  50-fold concentrate. 
Response of B cells alone, <12 PFC. Response of B cells plus FS6-14.13 Con ASn, 13 PFC. 1688  B  CELLS  REQUIRE  AT  LEAST  TWO  HELPER  FACTORS 
TABLE  V 
Correlation between the  T  Cell and B  Cell Stimulator), Activities of lL-2 
Produced by  Various T  Cell Hybrids 
Hybrid 
Units of IL-2/ml in hybrid Con ASn* 
HT-2 growth 
assay:~  B cell PFC assay§ 
FS7-59  1,800  444 
FS6-14.13  640  100 
FS8-4  320  27 
FS8-14  80  18 
FS8-1  40  <13 
FS7-8  <10  <13 
FS8-5  < 10  < 13 
FS8-7  <10  <13 
FS8-16  <10  <13 
* Hybrid cells incubated at 5 X 10  n to 10 X  105 cells/ml for 24 h with 
Con A. 
:~ As described in Materials and Methods. 
§ Calculated from data in Fig. 3. 
4/lg/ml 
assays,  1 unit  of IL-2 measured  in the  PFC  response  is equal  to  ~6  +  3  units  of IL-2 
in  the assay for T  cell growth. 
Taken  together,  these results make  a  very strong case for the identity  between  IL-2, 
defined  as  the  lymphokine  that  supports  the  growth  of continuous  T  cell  lines, and 
........................  NgrL~ ~  A Sn 
FS7-59  FSG-14,13  FSS-4 
I00  -i4 
I  I1,""" 
4;12~ 
I  2  5  I0  2O  5O  I00 
VOLUME OF HYBRID CON A SN (/JI) 
FIo.  2.  Ability of Con ASn of various T  cell hybrids to restore IL-2-depleted normal Con A Sn. 
Microcultures were prepared containing 1.5 X  105 T  cell-depleted B6D2F] spleen cells, SRBC, a- 
MM, and  1 #1 of 50  x  concentrated IL-2-depleted 4-d normal Con ASn. Cultures then received 
various amounts of Con ASn from one of the following T  cell hybrids: FS7-59 (O), FS6-14.13 (A), 
FS8-4  (I),  FS8-14  Or);  or FS7-8, FS8-1, FS8-5, FS8-7, or FS8-16  (0).  Cultures were assayed for 
anti-SRBC  PFC on day 4.  The results are shown as the total  number of anti-SRBC  PFC  in  12 
identical microcultures vs.  the amount  of T  cell hybrid Con ASn  added per microculture. Also 
shown is the response of control cultures that received 40 #1 of normal Con ASn not depleted of IL- 
2 (475 PFC/12 microcultures) and the estimated minimum detectable response (1 PFC/microcuhure 
or 12 PFC/12 microcultures). A unit of activity was defined as the amount of hybrid Con ASn per 
microculture that stimulated 75 PFC/12 microcuhures. (Halfway between 475 PFC and 12 PFC on 
the logl0 scale). Because 40 #1 was the most Sn that could be tested, the preparations with <1U/75 
#1 or 13 U/ml fell below the limit of detection. The units of activity/ml estimated for each of the 
hybrid Con ASn are listed in Table V. H. JAMES LEIBSON, PHILIPPA MARRACK, AND JOHN W.  KAPPLER  1689 
the  factor  in  FS6-14.13  Con  ASn  that  together  with  a  second  factor(s)  in  IL-2- 
depleted  normal  Con  A  Sn  supports  the  anti-SRBC  response  of severely  T  cell- 
depleted B cells. 
Sephadex G-IO0 Chromatography of lL-2-depleted Normal Con A Sn.  To begin to identify 
the components in IL-2-depleted normal Con ASn,  which with IL-2 were required 
for the anti-SRBC B cell response, we fractionated the absorbed Sn on Sephadex G- 
100. Fractions were assayed for their ability to support the anti-SRBC response of T 
cell-depleted  B  cells  in  the  presence or  absence of added  IL-2 Sn.  The  results  are 
shown in Fig. 3a. None of the fractions of the absorbed normal Con ASn  were able 
to support a response. However, when tested in the presence of FS6-14.13  Con ASn, 
which had little activity when tested alone, activity was revealed in the post bovine 
serum albumin fractions. The peak of this activity had an estimated ~40,000 mol wt. 
In a  reciprocal experiment (Fig. 3b), FS6-14.13  Con ASn was fractionated on the 
same  Sephadex  G-100  column.  The  fractions  were  assayed  both  for  their  T  cell- 
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FIo.  3.  Sephadex G-100 filtration of IL-2-depleted normal Con ASn and IL-2 Sn. A Sephadex G- 
100 column was prepared of approximate dimensions of 2.5 x  100 cm and equilibrated with 0.1 M 
ammonium bicarbonate. 7 ml of either normal C.on ASn that had been IL-2 depleted by incubation 
with Con A-activated spleen cells (panel a)  or FS6-14.13  Con ASn  (panel b)  were applied  and 
eluted with 0.l  M  ammonium bicarbonate.  19-ml fractions were taken, frozen, and lyopholized to 
remove water and ammonium bicarbonate. The residues were resuspended in 3 ml of medium. In 
panel a, each fraction was tested at 40% either alone (O)  or with 40% FS6-14.13 Con ASn  (0)  in 
the response of T  cell-depleted B6AFa spleen cells to SRBC. In panel b, each fraction was tested at 
30% either alone  (0)  or with  30% IL-2-depleted normal Con ASn  (0)  in the same response. In 
addition, these fractions were assayed for IL-2 activity using HT-2 cells, as described in Materials 
and Methods (hatched bars). The results are reported either as the total anti-SRBC PFC observed 
in  12 identical cultures or as units of IL-2 vs. the elution position. The molecular weight scale was 
determined  with  gamma globulin,  bovine  serum  albumin,  ovalbumin, chymotrypsinogen, and 
cytoehrome c. The void volume and total volume of the column are indicated. 1690  B CELLS REQUIRE  AT LEAST TWO HELPER FACTORS 
stimulating activity and their ability to stimulate an anti-SRBC response from T  cell- 
depleted B cells with or without added IL-2-depleted normal Con ASn. None of the 
fractions alone supported a  B cell response. However, addition of IL-2-depleted Con 
ASn,  which  failed to support  a  response by itself, revealed a  helper activity with a 
peak molecular weight of-40,000. The IL-2 activity measured by the support of HT- 
2 growth emerged in these same fractions. 
Discussion 
We continued  our efforts to define those helper factors in normal Con A  Sn  that 
were active in  stimulating  B  cell responses to  SRBC.  We demonstrated  that  when 
using as a B cell source spleen cells which had been thoroughly depleted of T  cells, at 
least two factors in normal Con ASn  were required  for a  response. The first factor 
was indistinguishable from IL-2. Its level in the Con ASn of FS6-14.13 and a number 
of other T  cell hybrids was directly correlated with IL-2 levels determined by support 
ofT cell growth. The activity could be removed from normal Con ASn by incubation 
with IL-2-dependent T  cells but not with various other types of cells. The activity had 
an apparent 40,000 mol wt as determined by Sephadex G-100 chromatography. The 
second factor(s)  was not produced  by FS6-14.13  and was not  absorbable with  IL-2- 
dependent  T  cells  but  also  had  an  apparent  molecular  weight  of  ~40,000,  as 
determined by Sephadex G-100 chromatography. 
These results indicate that  IL-2 is capable of influencing B cell responses without 
an intervening T  cell. This is a somewhat controversial point. Formerly called T  cell- 
growth factor, IL-2 was originally defined by its powerful growth-stimulating activity 
for activated T  cells (7, 8, 21).  Its helper activity in B cell responses was attributed to 
its ability to expand the activity of residual T  cells in the B cell preparations  (7, 8). 
Indeed, in support of this view, several laboratories have shown  (22,  23)  that T  cell 
lines  could  be  established  from  nude  mice  using  the  combination  of antigen  or 
mitogen activation and IL-2. Our findings and a  previous study (9)  confirmed that 
IL-2 required only a very small T cell contamination of B cells to appear as a sufficient 
helper factor and that no response was obtained if care was taken to deplete T  cells 
thoroughly.  However,  our  results  presented  here  indicate  that  IL-2  has  a  T  cell- 
independent  effect on  the  B  cell response as well.  These findings  are in  agreement 
with  those  of Parker  (24),  Howard  et  al.  (25),  and  Swain  et  al.  (26),  who  have 
demonstrated  that  IL-2  Sn  from  FS6-14.13  can  influence  B  cell  responses  in  the 
apparent absence of T  cells. It could be argued that FS6-14.13  produces two similar 
factors: IL-2 that is T  cell specific and a second factor capable of B cell stimulation. 
None of our experiments or those of others (24-26)  formally rule out this possibility; 
however, the extremely strong correlation between the T  cell- and B cell-stimulating 
activities  in  our experiments argues persuasively for a  direct  role of IL-2 in  B  cell 
responses without ruling out the existence of additional  B cell-specific lymphokines. 
It is not yet possible from our experiments to determine the role of IL-2 in the B 
cell response. It is tempting to suggest a  role for IL-2 as a  B cell growth factor. The 
experiments  of Parker  et  al.  (24)  in  fact  suggest  this  role.  Our  finding  that  high 
concentrations of LPS-activated B cell blasts fail to absorb IL-2 might argue against 
this possibility, but alternatively it might be that the requirement for IL-2 is dependent 
on the means of B cell activation (i.e.,  antigen vs. LPS). We have not as yet been able 
to generate enough antigen-activated B cell to attempt an absorption. Alternatively, H. JAMES LEIBSON, PHILIPPA MARRACK, AND JOHN W.  KAPPLER  1691 
it might be that IL-2 is not a growth factor for B cells but has some other effect on the 
B  cell  response.  Bifunctional  hormones  and  mediators  are  not  unprecedented  in 
immunological and other biological systems. 
We should stress that in the experiments reported here, although care was taken to 
deplete spleen  cells of T  cells,  no attempt was made to remove adherent  accessory 
cells,  such  as  macrophages.  Macrophage-produced  interleukin-1  (IL-1)  has  been 
reported as a B cell-helper factor and its synergy with IL-2 has been observed (27-29). 
The demonstration in our experiments that the non-T cell absorbable factor in normal 
Con  ASn  had  an  apparent  40,000  tool  wt  would  seem  to exclude  its  being IL-1, 
although it seems likely that in the absence of T  cells and macrophages, B cells may 
require IL-1 as well as IL-2 and this third factor for an optimal response. In fact, in 
preliminary experiments using IL-1 derived from the macrophage cell line P-388D1 
(30,  31), we have observed that it does not substitute for the non-T cell absorbable, 
40,000 mol wt, required factor and that both these factors and IL-2 are required by 
T  cell and macrophage-depleted B cells for an optimal response to SRBC. 
There are a number of reports of helper factors that might be identical to this non- 
IL-2  factor,  which  we  have  demonstrated  in  normal  Con  ASn.  Watson  and  his 
colleagues  demonstrated  a  factor  that  copurified  with  IL-2,  whose  activity  was 
manifested in B cell responses but not in T cell growth assays. This factor was partially 
resolved  from  IL-2  using  isoelectic  focusing  (7).  For  a  number  of years  Schimpl, 
Wecker, and their colleagues (2) have been studying the activity of a  factor that they 
term T  cell-replacing factor (TRF). Although the preparations in their early experi- 
ments  and  similar  preparations  studied  by  other  investigators  undoubtedly  also 
contained  IL-2 and perhaps IL-1, in  their more recent work (32)  they reported the 
separation of TRF from IL-2 on the basis of its physicochemical properties. Swain et 
al.  (26)  have recently demonstrated a  marked synergy between FS6-14.13-produced 
IL-2 and an IL-2-deficient Sn obtained from a  longterm alloreactive T  cell line.  As 
the  purification  of these  various  preparations  improves and  factors are exchanged 
between laboratories, it seems likely that some of these activities will be identical, and 
the naming of interleukin-3 will be justified. 
As a final point, we would like to reemphasize that our results demonstrate that the 
determination of the mode of B cell stimulation by helper factors depends not only on 
adequate sources of uncontaminated  factors but  also to as great  a  degree on B cell 
preparations uncontaminated with other cell types. 
Summary 
A helper factor(s) distinct from interleukin 2 (IL-2) was shown to be present in the 
concanavalin A-stimulated supernatant of normal mouse spleen cells (normal Con A 
Sn). Spleen cells thoroughly depleted of T  cells required both IL-2 and this factor to 
produce antibody-secreting cells  in  response to sheep erythrocytes,  although  in  the 
presence of IL-2 and a  few T  ceils the requirement  for the factor was less apparent. 
The factor had an apparent ~40,000 mol wt. The factor was found in normal Con A 
Sn that had been depleted of IL-2 by absorption with IL-2-dependent T  cells and was 
absent from Con A-stimulated supernatants of the IL-2-producing T  cell hybridoma, 
FS6-14.13. 
These results  indicate  that  multiple  helper  factors control  the  B  cell  response to 
antigen  and  that  IL-2, in  addition  to its T  cell growth  promoting activity, plays a 1692  B CELLS  REQUIRE  AT LEAST  TWO  HELPER  FACTORS 
direct role in B  cell responses. 
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